Technical Update - Maersk eyeing sub 10K levels. Novo higher but correction looming Technical Update - Maersk eyeing sub 10K levels. Novo higher but correction looming Technical Update - Maersk eyeing sub 10K levels. Novo higher but correction looming

Technical Update - Maersk eyeing sub 10K levels. Novo higher but correction looming

Equities 3 minutes to read
Kim Cramer Larsson

Technical Analyst, Saxo Bank

Summary:  Maersk is being hit hard after earnings disappointment and can very well re-visit sub 10K levels
Novo moving higher but uptrend stretched and indicators are warning about a short-term correction. Longer-term there could be further upside

A.P. Moller Maersk (B) is down approx. 14% after disappointing earnings announcement trading well below support at around 11,360.
Daily RSI is currently below 40 threshold and if closing below there is further downside potential for the beaten down share. No strong support until around 10,320-9,820.

The rising traded volume is further confirming the downtrend

For Maersk to demolish and reverse this bearish outlook a close of the gap created today i.e., a close above 12,185 is needed.
That scenario is quite unlikely to play out

Source all charts and data: Saxo Group

Novo Nordisk seems unstoppable. However, uptrend is short-term a bit stretched with daily RSI above 80. But there is no divergence indicating Novo could move higher before a correction is hitting.
A move to 839 which is 200% of the latest correction that took place in Q4 2023 – see weekly chart – is likely.

If Novo is closing around current trading levels – or higher – the RSI on the weekly chart has broken its falling trend. There will still be divergence however, but closing above its falling trendline is indicating the divergence could be cancelled. It will require an RSI close above the horizontal dashed line.

Long-term monthly chart Novo has cancelled its RSI divergence by closing January above the dashed line. Currently above 90 RSI is at an extreme (RSI values ranges from 0 to 100) i.e., massively overbought BUT there is no divergence suggesting Novo could continue higher. However, it is ripe for a correction.

There is a warning sign in the form of declining volume. Basically, less and less buyers are pushing the stock higher, that is not sustainable

Support area around 795.70-774.30. A close below could ignite a larger correction down to around 725-700  

We’ll keep an eye out for a top and reversal pattern to emerge
Author is holding a position in Novo

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (
- Full disclaimer (

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.